Participated 0 12 0 12 O
in 13 15 13 15 O
United 16 22 16 22 B-treatment
Therapeutics 23 35 23 35 I-treatment
Study 36 41 36 41 I-treatment
TDE 42 45 42 45 I-treatment
- 45 46 45 46 I-treatment
PH-310 46 52 46 52 I-treatment

